National and Kapodistrian University of Athens
Μελέτη έκφρασης γονιδίων ρύθμισης του κυτταρικού κύκλου σε διάχυτα από μεγάλα κύτταρα Β μη Hodgkin λεμφώματα: συμβολή στην προγνωστική αξιολόγηση
Abstract
dc:descriptionDiffuse large B-cell lymphoma (DLBCL) is an aggressive malignancy of mature B cells with heterogeneous prognosis. Biological markers have been used in an attempt to improve the discriminative capacity of the International Prognostic Index (IPI). Abnormalities of cell cycle constitute a marker of clonal expansion and may contribute to disease progression; thus the investigation of cell cycle regulatory genes may be of prognostic relevance. The aim of the present study was the investigation of gene expression levels of cell cycle regulatory genes in DLBCL and their relation to prognosis. The analysis included 45 newly diagnosed cases of diffuse large B-cell lymphomas and 18 cases of non-neoplastic lymphadenopathies used as controls. The IPI was available for all lymphoma cases. RNA was extracted from fresh frozen tissues and analyzed by RNase Protection Assay (RPA) with Riboquant kit (BD Biosciences). Two sets of probes were used that included cyclins, cyclin dependent kinases and their inhibitors. In more detail h-CC1 set of probes detected mRNA for the genes cdk-1, cdk-2, cdk-3, cdk-4, p16, p27, p21, PISSLRE and h-CYC1 set of probes detected mRNA for the genes of cyclins A, B, C, D1, D2, D3 and A1. The intensity of each band was compared to that of the housekeeping genes GAPDH and L32 using the Image Master Software (Pharmacia). Moreover, immunohistochemistry was performed on paraffin-embedded tissue sections in order to verify the expression of germinal center proteins, bcl6 and CD10 and MUM1/interferon regulatory factor (IRF)4.The expression levels of the cell cycle regulatory genes did not correlate with any of the clinical parameters nor the prognostic markers. 85% of patients that didn’t have complete remission to first line therapy, expressed the cyclinA1 (p=0,047). 92% of the patients with low IPI (0,1) expressed PISSLRE, while only 56% of the patients with high IPI (2,3,4,5), expressed this gene. Moreover, cdk2 and cdk4 expression levels were significantly higher in cases expressing bcl-6 protein (p=0,013, p=0,04 respectively). The mean expression level of cyclin B was higher in cases with positive expression of protein CD10 (p=0,007). All patients with negative expression of CD10 had a lower expression level of cyclinA1 compared to normal RNA pool (p=0,037). Moreover, patients expressing cyclinA1 had significantly shorter disease free survival (p=0,03), while the expression of PISSLRE was associated with significantly better overall survival (p=0,0329).Taking into consideration the heterogeneity of clinical behaviour of DLBCL, the cell cycle regulatory genes may serve as biologic markers with prognostic significance. Our study has shown that the expression level of cyclinA1 is associated with significantly lower response to first line therapy and lower disease free survival. Moreover the expression of PISSLRE seems to be associated with low risk disease and higher overall survival, which emphasizes the potential role of this gene as a tumour suppressor.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2010
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Kontsioti, Fragoula
- Κοντσιώτη, Φραγκούλα
Subjects
dc:subject × 20- Διάχυτα από μεγάλα κύτταρα Β μη Hodgkin λεμφώματα
- Κυτταρικός κύκλος
- Κυκλίνη Α1
- Κυκλίνη Β
- Κυκλινοεξαρτώμενες κινάσες
- Γονίδιο PISSLRE
- Γονίδια βλαστικού κέντρου
- Επιβίωση
- Diffuse large b-cell lymphoma
- Cell cycle
- Cyclin A1
- Cyclin B
- Cyclin dependent kinases
- PISSLRE gene
- Germinal centre proteins
- Survival
- Ιατρική και Επιστήμες Υγείας
- Βασική Ιατρική
- Medical and Health Sciences
- Basic Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/28934